Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$16.97
+2.3%
$16.31
$9.22
$21.00
$780.79M1.04833,663 shs486,910 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$27.32
+7.6%
$15.81
$9.76
$30.10
$776.71M1.19466,140 shs925,246 shs
Embecta Corp. stock logo
EMBC
Embecta
$14.10
+4.0%
$14.22
$9.20
$21.48
$824.71M1.1575,551 shs280,798 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$5.87
+1.2%
$5.74
$4.34
$11.87
$199.93M1.5399,747 shs44,037 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
0.00%+3.75%-3.55%+42.89%+26.06%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.00%-2.80%+126.61%+131.15%+88.56%
Embecta Corp. stock logo
EMBC
Embecta
0.00%+1.35%-5.44%+31.78%-0.59%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%-9.09%+17.41%-26.95%-39.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$16.97
+2.3%
$16.31
$9.22
$21.00
$780.79M1.04833,663 shs486,910 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$27.32
+7.6%
$15.81
$9.76
$30.10
$776.71M1.19466,140 shs925,246 shs
Embecta Corp. stock logo
EMBC
Embecta
$14.10
+4.0%
$14.22
$9.20
$21.48
$824.71M1.1575,551 shs280,798 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$5.87
+1.2%
$5.74
$4.34
$11.87
$199.93M1.5399,747 shs44,037 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
0.00%+3.75%-3.55%+42.89%+26.06%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.00%-2.80%+126.61%+131.15%+88.56%
Embecta Corp. stock logo
EMBC
Embecta
0.00%+1.35%-5.44%+31.78%-0.59%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%-9.09%+17.41%-26.95%-39.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
2.60
Moderate Buy$25.7551.74% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.50
Moderate Buy$19.67-28.01% Downside
Embecta Corp. stock logo
EMBC
Embecta
2.20
Hold$19.0034.75% Upside
Nyxoah SA stock logo
NYXH
Nyxoah
2.50
Moderate Buy$15.00155.54% Upside

Current Analyst Ratings Breakdown

Latest NYXH, EMBC, CLPT, and AXGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Embecta Corp. stock logo
EMBC
Embecta
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/8/2025
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/7/2025
Embecta Corp. stock logo
EMBC
Embecta
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
9/30/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$25.00
9/30/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$25.00
9/27/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Embecta Corp. stock logo
EMBC
Embecta
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
9/27/2025
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 10/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$187.34M4.17N/AN/A$2.36 per share7.19
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$31.39M24.74N/AN/A$0.92 per share29.70
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.73$3.47 per share4.06($12.80) per share-1.10
Nyxoah SA stock logo
NYXH
Nyxoah
$4.89M40.89N/AN/A$3.60 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$9.96M-$0.10N/AN/AN/A-2.29%-4.43%-2.34%10/29/2025 (Estimated)
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$18.91M-$0.81N/AN/AN/A-66.15%-94.44%-51.58%11/6/2025 (Estimated)
Embecta Corp. stock logo
EMBC
Embecta
$78.30M$1.439.864.590.757.58%-23.40%14.46%11/25/2025 (Estimated)
Nyxoah SA stock logo
NYXH
Nyxoah
-$64.10M-$2.30N/AN/AN/A-1,541.84%-79.18%-54.92%11/5/2025 (Estimated)

Latest NYXH, EMBC, CLPT, and AXGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.20N/AN/AN/A$9.60 millionN/A
11/5/2025Q3 2025
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.60N/AN/AN/AN/AN/A
10/29/2025Q3 2025
AxoGen, Inc. stock logo
AXGN
AxoGen
$0.09N/AN/AN/A$56.90 millionN/A
8/18/2025Q2 2025
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.62-$0.63-$0.01-$0.63$1.33 million$1.58 million
8/12/2025Q2 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.20-$0.21-$0.01-$0.21$9.20 million$9.22 million
8/8/2025Q3 2025
Embecta Corp. stock logo
EMBC
Embecta
$0.7720$1.12+$0.3480$0.78$278.15 million$295.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$0.604.26%N/A41.96%N/A
Nyxoah SA stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A

Latest NYXH, EMBC, CLPT, and AXGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.154.14%8/29/20258/29/20259/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.59
4.14
2.67
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.46
7.30
6.45
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.47
1.78
Nyxoah SA stock logo
NYXH
Nyxoah
0.29
2.63
2.38

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Embecta Corp. stock logo
EMBC
Embecta
93.83%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
2.78%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
Embecta Corp. stock logo
EMBC
Embecta
0.42%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45046.01 million44.73 millionOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11028.43 million26.69 millionOptionable
Embecta Corp. stock logo
EMBC
Embecta
2,10058.49 million58.24 millionOptionable
Nyxoah SA stock logo
NYXH
Nyxoah
11034.06 millionN/ANot Optionable

Recent News About These Companies

Nyxoah (NASDAQ:NYXH) Stock Price Down 3.1% - Should You Sell?
Publication relating to transparency notifications
Nyxoah Expands Middle East Presence with New Centers
Nyxoah (NASDAQ:NYXH) Shares Down 3.6% - Time to Sell?
Nyxoah Provides an Update on Expanded Middle East Presence
Publication relating to transparency notifications
Nyxoah Announces Upcoming Investor Events

New MarketBeat Followers Over Time

Media Sentiment Over Time

AxoGen stock logo

AxoGen NASDAQ:AXGN

$16.97 +0.38 (+2.29%)
Closing price 04:00 PM Eastern
Extended Trading
$16.98 +0.01 (+0.03%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$27.32 +1.94 (+7.64%)
Closing price 04:00 PM Eastern
Extended Trading
$27.44 +0.13 (+0.46%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Embecta stock logo

Embecta NASDAQ:EMBC

$14.10 +0.54 (+3.98%)
Closing price 04:00 PM Eastern
Extended Trading
$13.95 -0.15 (-1.09%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$5.87 +0.07 (+1.21%)
Closing price 04:00 PM Eastern
Extended Trading
$6.10 +0.24 (+4.00%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.